GBT
IDXX icon

Grove Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Grove Bank & Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$367K Sell
703
-7
-1% -$3.84K 0.04% 201
2026
Q2 		$374K Sell
710
-396
-36% -$222K 0.04% 197
2026
Q1 		$621K Sell
1,106
-654
-37% -$419K 0.07% 146
2025
Q4 		$1.19M Sell
1,760
-974
-36% -$663K 0.13% 102
2025
Q3 		$1.75M Sell
2,734
-173
-6% -$105K 0.2% 81
2025
Q2 		$1.56M Buy
2,907
+2,870
+7,757% +$1.37M 0.19% 85
2025
Q1 		$15.5K Hold
37
– – ﹤0.01% 553
2024
Q4 		$15.3K Buy
37
+5
+16% +$2.19K ﹤0.01% 495
2024
Q3 		$16.2K Buy
32
+12
+60% +$5.83K ﹤0.01% 458
2024
Q2 		$9.74K Sell
20
-5
-20% -$2.51K ﹤0.01% 483
2024
Q1 		$13.5K Hold
25
– – ﹤0.01% 473
2023
Q4 		$13.9K Hold
25
– – ﹤0.01% 462
2023
Q3 		$10.9K Hold
25
– – ﹤0.01% 511
2023
Q2 		$12.6K Sell
25
-7
-22% -$3.35K ﹤0.01% 486
2023
Q1 		$16K Buy
32
+27
+540% +$12.9K ﹤0.01% 477
2022
Q4 		$2K Buy
+5
New +$1.94K ﹤0.01% 571

Other funds holding IDXX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $283M AUM 29.49% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Grove Bank & Trust's IDXX Position: Q3 2026 in Review

Grove Bank & Trust reduced its Idexx Laboratories (IDXX) stake by 0.99% in Q3 2026, selling an estimated $3.84K and leaving 703 shares worth $367K. The position accounts for 0.04% of the portfolio, ranked #201.

Grove Bank & Trust first reported a position in IDXX in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.75M in Q3 2025. 35 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Grove Bank & Trust held 703 shares of Idexx Laboratories worth $367K as of Q3 2026.
  • Grove Bank & Trust sold 7 Idexx Laboratories shares in Q3 2026, an estimated $3.84K.
  • Idexx Laboratories made up 0.04% of Grove Bank & Trust's portfolio in Q3 2026, its #201 holding.
  • Grove Bank & Trust first reported a position in Idexx Laboratories in Q4 2022 and has held it in 16 quarters since.
  • Grove Bank & Trust's Idexx Laboratories position peaked at $1.75M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.